Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Other financing activities (2019 - 2025)

Bioadaptives' Other financing activities history spans 6 years, with the latest figure at $115000.0 for Q2 2025.

  • Quarterly results put Other financing activities at $115000.0 for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $47500.0 (changed N/A YoY), and the annual figure for FY2023 was -$2500.0, changed.
  • Other financing activities for Q2 2025 was $115000.0 at Bioadaptives, up from $90000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $115000.0 in Q2 2025 to a low of -$167500.0 in Q4 2023.
  • The 4-year median for Other financing activities is $42500.0 (2021), against an average of $15694.5.
  • The sharpest move saw Other financing activities skyrocketed 630.71% in 2021, then plummeted 86.67% in 2022.
  • Year by year, Other financing activities stood at -$28333.0 in 2021, then skyrocketed by 135.29% to $10000.0 in 2022, then crashed by 1775.0% to -$167500.0 in 2023, then soared by 168.66% to $115000.0 in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $115000.0, $90000.0, and -$167500.0 for Q2 2025, Q1 2025, and Q4 2023 respectively.